|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Pulmonary, Allergy and Critical Care Medicine; Center for Translational Research in the Lung
2 Division of Pulmonary, Allergy and Critical Care Medicine; Center for Translational Research in the Lung; Medicine, McKelvey Center for Lung Transplantation, Atlanta, Georgia, United States
* To whom correspondence should be addressed. E-mail: mrojas{at}emory.edu.
The reasons for variable sensitivity among and within species to lung injury and fibrosis caused by bleomycin are unknown. Since Th1-Th2 polarization of CD4+ T lymphocytes is one of the factors that affects the bleomycin response, we hypothesized that preventing expression of the Th1 transcription factor, T-bet, would render bleomycin resistant BALB/c mice sensitive to bleomycin. Wild type and T-bet deficient (T-bet-/-) BALB/c mice were treated with bleomycin or saline solution intratracheally. After bleomycin, collagen content in the lung in T-bet-/- mice doubled by day 14; collagen content in lungs from wild type BALB/c mice was unaffected by bleomycin. Those findings were confirmed by collagen staining of histopathological sections. Consistently, in bleomycin treated T-bet-/- mice, respiratory frequency increased and tidal volume decreased significantly by day 14 while respiratory variables were unaffected by bleomycin in wild type mice. Lung fibrosis in T-bet-/- mice after bleomycin treatment was associated with increased circulating levels of Th2 cytokines and increased expression of the pro-fibrotic factor TGF-
1. Depletion of CD4+ (but not CD8+) T cells in T-bet deficient mice diminished bleomycin-induced lung fibrosis, and expression of TGF-
1. These data suggest that T-bet pathway in CD4+ T lymphocytes can be one of the elements that confers resistance to bleomycin induced lung fibrosis in BALB/c mice.
This article has been cited by other articles:
![]() |
M. A. Queisser, F. M. Kouri, M. Konigshoff, M. Wygrecka, U. Schubert, O. Eickelberg, and K. T. Preissner Loss of RAGE in Pulmonary Fibrosis: Molecular Relations to Functional Changes in Pulmonary Cell Types Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Luzina, N. W. Todd, A. T. Iacono, and S. P. Atamas Roles of T lymphocytes in pulmonary fibrosis J. Leukoc. Biol., February 1, 2008; 83(2): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mora, E. Torres-Gonzalez, M. Rojas, J. Xu, J. Ritzenthaler, S. H. Speck, J. Roman, K. Brigham, and A. Stecenko Control of Virus Reactivation Arrests Pulmonary Herpesvirus-induced Fibrosis in IFN-{gamma} Receptor-deficient Mice Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1139 - 1150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |